The Partnership to Accelerate Clinical Trials is trying to eliminate the duplication of administration and regulation that can delay multicenter clinical trials by creating a centralized institutional review board and master clinical trial agreement recognized by research institutions across California.

The aim is to have at least five clinical trial sites across the state accept a common IRB and master clinical trial agreement by 2Q14 and have at least five clinical trials managed through the consortium's system by the end of next year.